NYSE: LYBLyondellbasell Industries Nv Stock
$92.07-1.37 (-1.47%)
Updated Oct 15, 2024
LYB Price
$92.07
Fair Value Price
N/A
Market Cap
$29.93B
52 Week Low
$88.46
52 Week High
$107.02
P/E
12.93x
P/B
2.23x
P/S
0.76x
PEG
1.15x
Dividend Yield
4.17%
Revenue
$41.04B
Earnings
$2.33B
Gross Margin
12.2%
Operating Margin
8.14%
Profit Margin
5.7%
Debt to Equity
1.76
Operating Cash Flow
$4B
Beta
1.19
Next Earnings
Nov 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A
LYB Overview
LyondellBasell Industries N.V. is a chemical producer that operates these segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company's customers its chemicals to manufacture a range of products that people use in their everyday lives including food packaging, home furnishings, automotive components, paints and coatings. LyondellBasell Industries was incorporated in 2009 and is headquartered in Houston, TX.
Zen Score
–
Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LYB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LYB ($92.07) is trading above its intrinsic value of $70.35, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LYB is good value based on its earnings relative to its share price (12.93x), compared to the US market average (26.94x)
P/E vs Market Valuation
LYB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more LYB due diligence checks available for Premium users.
Be the first to know about important LYB news, forecast changes, insider trades & much more!
LYB News
Valuation
LYB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
12.93x
Industry
33.77x
Market
26.94x
LYB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LYB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
LYB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.23x
Industry
3.69x
LYB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LYB price to earnings growth (PEG)
For valuing profitable companies with growth potential
LYB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
LYB's financial health
Profit margin
Revenue
$10.6B
Net Income
$924.0M
Profit Margin
8.7%
LYB's Earnings (EBIT) of $3.34B... subscribe to Premium to read more.
Interest Coverage Financials
LYB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$37.1B
Liabilities
$23.6B
Debt to equity
1.76
LYB's short-term assets ($12.91B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LYB's long-term liabilities ($17.45B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LYB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LYB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.3B
Investing
-$313.0M
Financing
-$481.0M
LYB's operating cash flow ($4.40B)... subscribe to Premium to read more.
Debt Coverage Financials
LYB vs Specialty Chemical Stocks
Lyondellbasell Industries Nv Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.